Search - tctmd.com

Displaying 521 - 540 of 589

Sort: Relevancy | Date

News Daily News

Left, Right Radial Procedures Equally Effective, but Right Access Takes Longer

Jason Kahn

June 08, 2012

News Industry News

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent

May 17, 2012

News Industry News

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

May 16, 2012

News Industry News

Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System

May 14, 2012

News Conference News SCAI 2012

MOBILITY Supports Iliac Stenting in Extensive PAD Cases

Caitlin E. Cox

May 11, 2012

News Industry News

Medtronic Announces Global Drug-Eluting Balloon Study

April 17, 2012

News Industry News

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

April 13, 2012

News Daily News

Imaging Dominates ACC’s Top 5 Overused Procedures, Tests

Yael L. Maxwell

April 11, 2012

News Conference News ACC 2012

ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease

Yael L. Maxwell

March 27, 2012

News Conference News ACC 2012

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

L.A. McKeown

March 24, 2012

News Daily News

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Jason Kahn

March 22, 2012

News Industry News

Acute Results of the CorPath PRECISE Trial for Robotic-Assisted PCI to be Presented at ACC 2012

March 22, 2012

News Daily News

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Caitlin E. Cox

March 12, 2012

News Industry News

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

March 06, 2012

News Daily News

Live Case Procedures Just as Safe as in Daily Practice

Caitlin E. Cox

February 21, 2012

News Industry News

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

February 07, 2012

News Industry News

Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries

February 07, 2012

News Industry News

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

January 15, 2012

News Daily News

Fewer Vascular Complications as TAVR Evolves

Caitlin E. Cox

January 10, 2012

News Industry News

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

December 31, 2011

Advertisement

Left, Right Radial Procedures Equally Effective, but Right Access Takes Longer

Boston Scientific Announces FDA Approval and U.S. Launch of EPIC™ Vascular Stent

Medtronic IN.PACT Drug-Eluting Balloon Studies Show Significant Benefit of Novel Medical Device in Treating Narrowed Arteries

Boston Scientific Announces CE Mark and European Launch of Innova™ Self-expanding Bare-metal Stent System

MOBILITY Supports Iliac Stenting in Extensive PAD Cases

Medtronic Announces Global Drug-Eluting Balloon Study

Medtronic Initiates Landmark U.S. Drug-Eluting Balloon Study

Imaging Dominates ACC’s Top 5 Overused Procedures, Tests

ASCERT: Long-term Survival Advantage with CABG in Multivessel Disease

New Antiplatelet Agent Vorapaxar Shows Promise, But At the Expense of Bleeding

Drug-Eluting Balloon Continues Strong Showing in SFA Lesions

Acute Results of the CorPath PRECISE Trial for Robotic-Assisted PCI to be Presented at ACC 2012

In-Hospital Bleeding, Mortality Linked Long After NSTEMI

Abbott's Absolute Pro® Vascular Self-Expanding Stent System Receives FDA Approval for Treatment of Iliac Artery Disease

Live Case Procedures Just as Safe as in Daily Practice

Medtronic Stent Resulted in 90% Freedom from Reinterventions in Narrowed Leg Arteries at 12 Months in International Study

Boston Scientific Launches Innovative Crossing Device to Treat Complete Blockages in Peripheral Arteries

Boston Scientific Epic™ Stent Demonstrates Positive Clinical Outcomes in Orion Trial

Fewer Vascular Complications as TAVR Evolves

Abbott Initiates Clinical Trial To Study Drug Eluting Bioresorbable Therapy For Treatment Of Peripheral Artery Disease

Advertisement

Advertisement

Sign In

Forgot Your Password?

Search TCTMD

CME TITLE

Sign up for our newsletter

Search TCTMD

Submit an Event

Become a PREMIUM MEMBER or LOG IN to view exclusive content

REGISTER for free or LOG IN to view this content